Mina M. Fam, MD, discusses some of the common misconceptions that patients have when seeking testosterone replacement therapy.

Benjamin M. Brucker, MD, outlines considerations surrounding pre-procedure urinalysis, prophylactic periprocedural antibiotics, and optimal dosing regimens for onabotA administration.

The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for nogapendekin alfa inbakicept-pmln (NAI, Anktiva) in combination with BCG for the ...

Treatment of non-metastatic hormone-sensitive prostate cancer (nmHSPC) with enzalutamide (Xtandi) in combination with leuprolide acetate was associated with significantly improved overall survival (OS ...

On June 18, 2025, the FDA granted clearance to Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for the treatment of patients with urinary urge incontinence. 1 In this video, Andrea ...

Patient enrollment has been completed for the phase 3 UTOPIA trial (NCT06331299) evaluating UGN-103 (mitomycin) for intravesical solution for the treatment of recurrent low-grade intermediate risk non ...

Anne K. Schuckman, MD, discusses some of the current challenges in delivering optimal care for patients with non–muscle invasive bladder cancer.

The FDA and European Medicines Agency (EMA) have granted authorization for a confirmatory phase 3 trial that will evaluate masitinib in metastatic castrate-resistant prostate cancer (mCRPC), AB ...

Zelenectide pevedotin plus pembrolizumab demonstrated a 65% objective response rate in cisplatin-ineligible urothelial carcinoma patients. The combination treatment was generally tolerable, with ...

The FDA granted 510(k) clearance to the Glean Urodynamics System for lower urinary tract dysfunction, enabling wireless, catheter-free monitoring. Darolutamide received FDA approval for metastatic ...

The uniqueness of this study lies in its focus on NMIBC, as the role of ctDNA is well-established in more advanced diseases but less so in the non–muscle invasive space, where systemic circulating ...

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.